NewsInfraReDx's LipiScan Coronary Imaging System for Identification of Lipid Core Plaque to be Highlighted at 59th Annual Scientific Session of the American College of Cardiology March 10, 2010 InfraReDx, Inc., an innovative medical device company focused on developing novel diagnostic imaging technologies to accurately identify and characterize diseased intracoronary tissues, today announced that the Company's LipiScan Coronary Imaging System will be highlighted in multiple sessions during the 59th Annual Scientific Session of the American College of Cardiology (ACC). InfraReDx to Showcase LipiScan Coronary Imaging System for Identification of Lipid Core Plaque at LUMEN 2010 February 24, 2010 InfraReDx, Inc., an innovative medical device company focused on developing novel diagnostic imaging technologies to accurately identify and characterize diseased intracoronary tissues, today announced that the Company will be exhibiting at LUMEN 2010, the world?s premier ST-elevation myocardial infarction (STEMI) meeting, to be held February 25-27, 2010 at the Loews Miami Beach Hotel in Miami Beach, Florida. InfraReDx CEO to Discuss Vulnerable Plaque Identification with LipiScan Coronary Imaging System at Cardiovascular Research Technologies 2010 Forum February 18, 2010 InfraReDx, Inc., an innovative medical device company focused on developing novel diagnostic imaging technologies to accurately identify and characterize diseased intracoronary tissues, today announced that the Company?s founder and chief executive officer, James E. Muller, M.D., will present and participate in a number of sessions and panel discussions during the annual Cardiovascular Research Technologies (CRT) 2010 meeting. InfraReDxs LipiScan System Featured at Scottsdale Interventional Forum February 11, 2010 InfraReDx, Inc., an innovative medical device company focused on developing novel diagnostic imaging technologies to accurately identify and characterize diseased tissues, today announced that its commercially available LipiScan? Coronary Imaging System will be featured at the Scottsdale Interventional Forum, an international conference for Interventional Cardiologists and other healthcare professionals. Novel Information about Vulnerable Coronary Artery Plaque to be Presented at Transcatheter Cardiovascular Therapeutics (TCT) 2009 September 21, 2009 The TCT 2009 meeting will feature an unusual amount of novel information about Vulnerable Coronary Artery Plaque, the structure widely considered to the primary cause of acute coronary events, the leading cause of death in the developed world. InfraReDx to showcase the LipiScan™ Coronary Imaging System at the Cardiovascular Research Foundation's (CRF) annual Transcatheter Cardiovascular Therapeutics (TCT) scientific meeting September 11, 2009 Results of Initial Clinical Experience with a Novel Spectroscopy Catheter that can Identify Lipid-Core Coronary Plaques to be presented at TCT 2009 First use in coronary patients of a combined near-infrared spectroscopy and ultrasound imaging catheter. May 11, 2009 InfraReDx, Inc. announced today the first use in patients of a novel coronary catheter that uses both light and sound to image coronary plaques. Results of Initial Clinical Experience with a Novel Spectroscopy Catheter that can Identify Lipid-core Coronary Plaques to be Presented at TCT October 10, 2008 InfraReDx to Showcase the LipiScanTM Coronary Imaging System at TCT 2008 FDA Grants Market Clearance for the LipiScan® Coronary Imaging System Developed By InfraReDx, Inc. October 6, 2008 The live case demonstrations at TCT 2007 will for the first time feature the use of a novel NIR imaging system recently developed by InfraReDx, Inc., a privately-held medical device company. Detection of Lipid Core Coronary Plaques in Autopsy Specimens With a Novel Catheter- Based Near-Infrared Spectroscopy System September 1, 2008 This study sought to assess agreement between an intravascular near-infrared spectroscopy (NIRS) system and histology in coronary autopsy specimens. The status of development of novel methods to prevent sudden cardiac death due to rupture of cholesterol plaques June 16, 2008 The sudden death of Tim Russert of NBC news is a public reminder of the many tragic deaths caused by coronary artery disease. First Use in a Patient of The InfraReDx LipiScan® Coronary Imaging System May 8, 2008 InfraReDx, Inc. today announced that physicians at Beaumont Hospital in Royal Oak, Mich., have successfully used its LipiScan? Coronary Imaging System in a patient undergoing a cardiac catheterization. A Novel Near-Infrared Spectroscopy System to Characterize Coronary Plaques Will Be Featured at TCT 2007 October 15, 2007 The live case demonstrations at TCT 2007 will for the first time feature the use of a novel NIR imaging system recently developed by InfraReDx, Inc., a privately-held medical device company. Heart Research Shifts to Early Detection November 9, 2006 Click Here InfraReDx Announces FDA Clearance of its Near Infrared Spectroscopic System for Examining Coronary Arteries October 19, 2006 InfraReDx today announced that the U. S. Food and Drug Administration recently issued a clearance for the company?s 510(k) application to market its near infrared (NIR) spectroscopic system for examining coronary arteries. InfraReDx to Play Active Role in 18th Annual Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium in Washington October 17, 2006 InfraReDx, Inc., a company that is investigating the use of near-infrared (NIR) spectroscopy for the detection of lipid-rich coronary artery plaque, will present its progress at the Cardiovascular Research Foundation?s 18th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium |
|